Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine add-on to sertraline for major depressive disorder
IRCT20170606034348N4Phase 2Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of memantine in major depressive disorder (MDD), sponsored by Babol University of Medical Sciences. Started Feb 2019; status: completed.
02
Drugs
memantine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20170606034348N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170606034348N4.